Riskpilot← Back to searchSign inGet full accessREIME BIOTEK AS
ASActiveOrg 985309434Sandavegen 15, 3802 Bø I TelemarkResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20037 employeeswww.reime.no
Revenue 2024
NOK 15,9M
-32% vs 2023
EBITDA margin
-111.4%
-19% vs 2023
Equity ratio
-170.8%
Financial strength
Net profit 2024
NOK -19M
-23% vs 2023
| Revenue | NOK 15,9M | -32% |
| EBITDA | NOK -17,7M | -19% |
| Net profit | NOK -19M | -23% |
| Total assets | NOK 8,7M | -38% |
| Equity | NOK -14,8M | +21% |
| Employees | 7 | — |
Legal name
REIME BIOTEK AS
Org number
985309434
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31. januar 2003
Share capital
NOK 23 177 097
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Utvikle, kommersialisere og levere anlegg for biogassproduksjon og gjenvinning av næringssalter til landbruket, oppdrettsnæringen og det offentlige.
Address
Sandavegen 15, 3802 Bø I Telemark
Website
www.reime.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 549 | 1 605 | 5 617 | 23 393 | 15 866 |
| Staff expenses | −0 | −0 | −1 371 | −3 486 | −5 277 |
| EBITDA | 1 353 | −7 | −3 496 | −14 908 | −17 674 |
| Depreciation & amort. | −58 | −0 | −11 | −57 | −445 |
| EBIT | 1 295 | −7 | −3 508 | −14 964 | −18 119 |
| Net financials | 1 | −10 | −21 | −465 | −872 |
| Profit before tax | 1 296 | −17 | −3 529 | −15 430 | −18 991 |
| Tax | −14 | −0 | −0 | −0 | −0 |
| Net profit | 1 310 | −17 | −3 529 | −15 430 | −18 991 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 269 | 2 507 | 10 579 | 13 897 | 8 650 |
| Equity | 292 | 275 | −3 254 | −18 684 | −14 772 |
| Long-term debt | 2 135 | 2 035 | 2 101 | 6 839 | 10 534 |
| Short-term debt | 2 842 | 196 | 11 732 | 25 741 | 12 889 |
| Total debt | 4 977 | 2 232 | 13 833 | 32 581 | 23 423 |
EBITDA margin
-111.4%
This company
15.8%
Market median
-805% vs market
20202024
Equity ratio
-170.8%
This company
38.2%
Market median
-547% vs market
20202024
Return on equity
-1899136100.0%
This company
18.4%
Market median
-10321391948% vs market
20202024
Net profit margin
-119.7%
This company
8.1%
Market median
-1578% vs market
20202024
Asset turnover
1.83×
This company
1.12×
Market median
+63% vs market
20202024
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SR Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
HO Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
KH Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Chairman | 2023 | |
| Board of Directors | 2024 | |
| Board of Directors | 2023 | |
| Former (6) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2021 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60.16% | 60.16% | 2024 | |
| Company | 39.83% | 39.83% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Telemark Energy As
REIME BIOTEK AS Board members of REIME BIOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hallgeir Ofte | Chief Executive Officer | 0 companies |
| Simen Rogne | Chief Executive Officer | 0 companies |
| Kristian Haug | Chief Executive Officer | 0 companies |
| Jon Hovland | Board of Directors | 0 companies |
| Vegard Schanche | Board of Directors | 0 companies |
| Eivind Lønheim | Chairman | 0 companies |
| Erling Johannes Ølstad | Board of Directors | 0 companies |
| Inge Vikesdal | Board of Directors | 0 companies |
| Bjørn Rygg | Chairman | 0 companies |
| Rune Bakke | Chairman | 0 companies |
| Torgeir Straand | Board of Directors | 0 companies |
| Olav Østhus | Board of Directors | 0 companies |
| Øivind Rui | Board of Directors | 0 companies |